Showing results (1-10 of 644) with videos related to
Sort By:
Pageof 65
American Journal of Hypertension|May 23, 2001
Mechanisms of diabetic vasculopathy: an overviewM E Cooper, F Bonnet, M Oldfield, et al.Diabetes & Metabolism|January 3, 2015
Beyond Glycosuria: Exploring the intrarenal effects of SGLT₋₂ inhibition in diabetesM C Thomas, K Jandeleit-Dahm, F BonnetDiabetologia|April 7, 2007
Plasminogen activator inhibitor-1 production is pathogenetic in experimental murine diabetic renal diseaseM Lassila, K Fukami, K Jandeleit-Dahm, et al.Kidney International. Supplement|July 21, 1999
Role of hyperlipidemia in progressive renal disease: focus on diabetic nephropathyK Jandeleit-Dahm, Z Cao, A J Cox, et al.Diabetes & Metabolism|September 30, 2000
Potential influence of lipids in diabetic nephropathy: insights from experimental data and clinical studiesF Bonnet, M E CooperMicrovascular Research|January 8, 2000
SPARC gene expression is increased in diabetes-related mesenteric vascular hypertrophyK Jandeleit-Dahm, J Rumble, A J Cox, et al.Hypertension (Dallas, Tex. : 1979)|October 21, 2000
Blockade of the renin-angiotensin and endothelin systems on progressive renal injuryZ Cao, M E Cooper, L L Wu, et al.Experimental Nephrology|September 11, 2001
Apoptosis and angiotensin II: yet another renal regulatory system?F Bonnet, Z Cao, M E CooperDiabetic Medicine : a Journal of the British Diabetic Association|December 21, 2010
Large artery biomechanics and diastolic dysfunctionin patients with Type 2 diabetesG Soldatos, K Jandeleit-Dahm, H Thomson, et al.Circulation Research|January 11, 2000
Diabetes-induced vascular hypertrophy is accompanied by activation of Na(+)-H(+) exchange and prevented by Na(+)-H(+) exchange inhibitionK Jandeleit-Dahm, K M Hannan, C A Farrelly, et al.Pageof 65